Literature DB >> 12107084

Immunization delays the onset of prion disease in mice.

Einar M Sigurdsson1, David R Brown, Maki Daniels, Richard J Kascsak, Regina Kascsak, Richard Carp, Harry C Meeker, Blas Frangione, Thomas Wisniewski.   

Abstract

The outbreak of new variant Creutzfeldt-Jakob disease has raised the specter of a potentially large population being at risk to develop this prionosis. None of the prionoses currently have an effective treatment. Recently, vaccination has been shown to be effective in mouse models of another neurodegenerative condition, namely Alzheimer's disease. Here we report that vaccination with recombinant mouse prion protein delays the onset of prion disease in mice. Vaccination was performed both before peripheral prion exposure and after exposure. A delay in disease onset was seen in both groups, but was more prolonged in animals immunized before exposure. The increase in the incubation period closely correlated with the anti-prion protein antibody titer. This promising finding suggests that a similar approach may work in humans or other mammalian species at risk for prion disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107084      PMCID: PMC1850699          DOI: 10.1016/S0002-9440(10)64151-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

Review 1.  Prions and the lymphoreticular system.

Authors:  C Weissmann; A J Raeber; F Montrasio; I Hegyi; R Frigg; M A Klein; A Aguzzi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-02-28       Impact factor: 6.237

2.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

3.  Immunodiagnosis of prion disease.

Authors:  R J Kascsak; R Fersko; D Pulgiano; R Rubenstein; R I Carp
Journal:  Immunol Invest       Date:  1997 Jan-Feb       Impact factor: 3.657

4.  Porphyrin and phthalocyanine antiscrapie compounds.

Authors:  S A Priola; A Raines; W S Caughey
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

Review 5.  Prion diseases and the immune system.

Authors:  P Aucouturier; R I Carp; C Carnaud; T Wisniewski
Journal:  Clin Immunol       Date:  2000-08       Impact factor: 3.969

6.  Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.

Authors:  E M Sigurdsson; H Scholtzova; P D Mehta; B Frangione; T Wisniewski
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie.

Authors:  P Aucouturier; F Geissmann; D Damotte; G P Saborio; H C Meeker; R Kascsak; R Kascsak; R I Carp; T Wisniewski
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

8.  Potent inhibition of scrapie-associated PrP accumulation by congo red.

Authors:  B Caughey; R E Race
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

9.  Sulphate polyanions prolong the incubation period of scrapie-infected hamsters.

Authors:  A Ladogana; P Casaccia; L Ingrosso; M Cibati; M Salvatore; Y G Xi; C Masullo; M Pocchiari
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

10.  Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters.

Authors:  M Pocchiari; S Schmittinger; C Masullo
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

View more
  43 in total

1.  Transmissible Spongiform Encephalopathy (TSE): vaccinal approach using the hamster model.

Authors:  C Pollera; M Caramelli; M L Giannino; P A Martino; M Puricelli; C Casalone; P Gazzuola; G Poli
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

Review 2.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

3.  In vitro neutralization of prions with PrP(Sc)-specific antibodies.

Authors:  Ryan Taschuk; Jacques Van der Merwe; Kristen Marciniuk; Andrew Potter; Neil Cashman; Philip Griebel; Scott Napper
Journal:  Prion       Date:  2015       Impact factor: 3.931

4.  Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.

Authors:  Gaetano Donofrio; Frank L Heppner; Magdalini Polymenidou; Christine Musahl; Adriano Aguzzi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 6.  Immunization treatment approaches in Alzheimer's and prion diseases.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 7.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

8.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

9.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice.

Authors:  Fabio Moda; Chiara Vimercati; Ilaria Campagnani; Margherita Ruggerone; Giorgio Giaccone; Michela Morbin; Lorena Zentilin; Mauro Giacca; Ileana Zucca; Giuseppe Legname; Fabrizio Tagliavini
Journal:  Prion       Date:  2012-07-30       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.